Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v7-FR
Language English French
Date Updated 2019-08-21 2019-06-28
Drug Identification Number 02087316 02087316
Brand name LEUCOVORIN CALCIUM INJECTION LEUCOVORIN CALCIUM INJECTION
Common or Proper name LEUCOVORIN LEUCOVORIN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients LEUCOVORIN LEUCOVORIN
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 50ML 50ML
ATC code V03AF V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-07-15 2019-07-15
Actual start date 2019-06-27 2019-06-27
Estimated end date 2019-10-30 2019-09-30
Actual end date 2019-08-20
Shortage status Resolved Actual shortage
Company comments Inventory released August 9th and allocating 80% of total market demand.
Health Canada comments